Lyka Labs (LYKALABS)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹59.21 |
| Market Cap | ₹222.53 Cr |
| P/E Ratio | 0 |
| ROCE | 9.91% |
| ROE | -0.94% |
| Dividend Yield | 0% |
| Profit Growth | -100% |
| Debt/Equity | — |
| Sales Growth | -9.08% |
| Promoter Holding | 58.16% |
| 52-Week Range | ₹44.1 — ₹125.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹37.13 |
Lyka Labs trades with ROCE of 9.91%, ROE of -0.94%, profit growth of -100%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer